Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 607531, 9 pages
http://dx.doi.org/10.1155/2015/607531
Research Article

Quercetin Alleviates High-Fat Diet-Induced Oxidized Low-Density Lipoprotein Accumulation in the Liver: Implication for Autophagy Regulation

1College of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, China
2Hubei Collaborative Innovation Center for Processing of Agricultural Products, Wuhan Polytechnic University, Wuhan 430023, China
3National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
4Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received 7 July 2015; Revised 23 October 2015; Accepted 4 November 2015

Academic Editor: Stephen H. Safe

Copyright © 2015 Liang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. N. Than and P. N. Newsome, “A concise review of non-alcoholic fatty liver disease,” Atherosclerosis, vol. 239, no. 1, pp. 192–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Moore, “Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome,” Proceedings of the Nutrition Society, vol. 69, pp. 211–220, 2010. View at Publisher · View at Google Scholar
  3. V. Bieghs, P. J. van Gorp, S. M. A. Walenbergh et al., “Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice,” Hepatology, vol. 56, no. 3, pp. 894–903, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. A. Walenbergh, G. H. Koek, V. Bieghs, and R. Shiri-Sverdlov, “Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins,” Journal of Hepatology, vol. 58, no. 4, pp. 801–810, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Bieghs, F. Verheyen, P. J. van Gorp et al., “Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in kupffer cells,” PLoS ONE, vol. 7, no. 3, Article ID e34378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Bieghs, K. Wouters, P. J. van Gorp et al., “Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice,” Gastroenterology, vol. 138, no. 7, pp. 2477–2486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Bieghs, S. M. A. Walenbergh, T. Hendrikx et al., “Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation,” Liver International, vol. 33, no. 7, pp. 1056–1061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Lougheed, H. F. Zhang, and U. P. Steinbrecher, “Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages,” The Journal of Biological Chemistry, vol. 266, no. 22, pp. 14519–14525, 1991. View at Google Scholar · View at Scopus
  10. J. Herrmann, S. M. Soares, L. O. Lerman, and A. Lerman, “Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease,” Journal of the American College of Cardiology, vol. 51, no. 21, pp. 2003–2010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-L. Zhang, Y.-J. Cao, X. Zhang et al., “The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 394, no. 2, pp. 377–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. G. L. Hertog, E. J. M. Feskens, P. C. H. Hollman, M. B. Katan, and D. Kromhout, “Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study,” The Lancet, vol. 342, no. 8878, pp. 1007–1011, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Kühnau, “The flavonoids. A class of semi-essential food components: their role in human nutrition,” World Review of Nutrition and Dietetics, vol. 24, pp. 117–191, 1976. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Lin, K. M. Rexrode, F. Hu et al., “Dietary intakes of flavonols and flavones and coronary heart disease in US women,” American Journal of Epidemiology, vol. 165, no. 11, pp. 1305–1313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Sampson, E. Rimm, P. C. H. Hollman, J. H. M. De Vries, and M. B. Katan, “Flavonol and flavone intakes in US health professionals,” Journal of the American Dietetic Association, vol. 102, no. 10, pp. 1414–1420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-Z. Ying, Y.-H. Liu, B. Yu, Z.-Y. Wang, J.-N. Zang, and C.-H. Yu, “Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils,” Food and Chemical Toxicology, vol. 52, pp. 53–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. M. Surapaneni, V. V. Priya, and J. Mallika, “Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH),” European Review for Medical and Pharmacological Sciences, vol. 18, no. 18, pp. 2736–2741, 2014. View at Google Scholar
  18. K. M. Surapaneni and M. Jainu, “Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis,” Journal of Physiology and Pharmacology, vol. 65, no. 1, pp. 67–74, 2014. View at Google Scholar · View at Scopus
  19. S. Vidyashankar, V. R. Sandeep, and P. S. Patki, “Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells,” Toxicology in Vitro, vol. 27, no. 2, pp. 945–953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Marcolin, B. San-Miguel, D. Vallejo et al., “Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis,” Journal of Nutrition, vol. 142, no. 10, pp. 1821–1828, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Pisonero-Vaquero, Á. Martínez-Ferreras, M. V. García-Mediavilla et al., “Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of non-alcoholic fatty liver disease,” Molecular Nutrition & Food Research, vol. 59, no. 5, pp. 879–893, 2015. View at Publisher · View at Google Scholar
  22. C. H. Jung, I. Cho, J. Ahn, T.-I. Jeon, and T.-Y. Ha, “Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes,” Phytotherapy Research, vol. 27, no. 1, pp. 139–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. É. Marcolin, L. F. Forgiarini, G. Rodrigues et al., “Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis,” Basic and Clinical Pharmacology and Toxicology, vol. 112, no. 6, pp. 385–391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. K. Klappan, S. Hones, I. Mylonas, and A. Brüning, “Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity,” Histochemistry and Cell Biology, vol. 137, no. 1, pp. 25–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Zhang, L.-X. Chen, L. Ouyang, Y. Cheng, and B. Liu, “Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents,” Cell Proliferation, vol. 45, no. 5, pp. 466–476, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Wang, R. Liu, J. Li et al., “Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling,” Autophagy, vol. 7, no. 9, pp. 966–978, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Saeed, F. Otsuka, R. Polavarapu et al., “Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 299–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Tang, Y. Li, H. Yu et al., “Quercetin prevents ethanol-induced iron overload by regulating hepcidin through the BMP6/SMAD4 signaling pathway,” Journal of Nutritional Biochemistry, vol. 25, no. 6, pp. 675–682, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  30. N. Grewal, G. M. Thornton, H. Behzad et al., “Accumulation of oxidized LDL in the tendon tissues of C57BL/6 or apolipoprotein E knock-out mice that consume a high fat diet: potential impact on tendon health,” PLoS ONE, vol. 9, no. 12, Article ID e114214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. K. Dyson, Q. M. Anstee, and S. McPherson, “Non-alcoholic fatty liver disease: a practical approach to treatment,” Frontline Gastroenterol, vol. 5, pp. 277–286, 2014. View at Publisher · View at Google Scholar
  32. G. Kanuri and I. Bergheim, “In vitro and in vivo models of Non-Alcoholic Fatty Liver Disease (NAFLD),” International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11963–11980, 2013. View at Publisher · View at Google Scholar
  33. B. W. Smith and L. A. Adams, “Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment,” Nature Reviews Endocrinology, vol. 7, no. 8, pp. 456–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Sookoian and C. J. Pirola, “Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review,” Journal of Hepatology, vol. 49, no. 4, pp. 600–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Arcaro, and C. Day, “Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C,” Journal of Hepatology, vol. 46, no. 6, pp. 1126–1132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Brea, D. Mosquera, E. Martín, A. Arizti, J. L. Cordero, and E. Ros, “Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 1045–1050, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Luo, X. Dong, Y. Yu, G. Sun, and X. Sun, “Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE−/− mice,” Journal of Ethnopharmacology, vol. 163, pp. 241–250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kampschulte, C. Stöckl, A. C. Langheinrich et al., “Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis,” Laboratory Investigation, vol. 94, no. 11, pp. 1273–1282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. C. Morrison, W. Liang, P. Mulder et al., “Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE3Leiden mice,” Journal of Hepatology, vol. 62, no. 5, pp. 1180–1186, 2015. View at Publisher · View at Google Scholar
  40. A. Stachowicz, R. Olszanecki, M. Suski et al., “Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice,” Journal of the American Heart Association, vol. 3, no. 6, Article ID e001329, 2014. View at Publisher · View at Google Scholar
  41. K. Wouters, P. J. van Gorp, V. Bieghs et al., “Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis,” Hepatology, vol. 48, no. 2, pp. 474–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. V. V. Kunjathoor, M. Febbraio, E. A. Podrez et al., “Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages,” The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49982–49988, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Yao, H. Sang, G. Song et al., “Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway,” Experimental Biology and Medicine, vol. 237, no. 7, pp. 822–831, 2012. View at Publisher · View at Google Scholar
  44. H. J. Choi, J. H. Song, and D. H. Kwon, “Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice,” Phytotherapy Research, vol. 26, no. 3, pp. 462–464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. O. J. Lara-Guzman, J. H. Tabares-Guevara, Y. M. Leon-Varela et al., “Proatherogenic macrophage activities are targeted by the flavonoid quercetin,” Journal of Pharmacology and Experimental Therapeutics, vol. 343, no. 2, pp. 296–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. V. J. Lavallard and P. Gual, “Autophagy and non-alcoholic fatty liver disease,” BioMed Research International, vol. 2014, Article ID 120179, 13 pages, 2014. View at Publisher · View at Google Scholar
  47. W. J. Kwanten, W. Martinet, P. P. Michielsen, and S. M. Francque, “Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7325–7338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. Yimin, H. Furumaki, S. Matsuoka et al., “A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein,” Laboratory Investigation, vol. 92, no. 2, pp. 265–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. B.-L. Chen, L.-T. Wang, K.-H. Huang, C.-C. Wang, C.-K. Chiang, and S.-H. Liu, “Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway,” Journal of Nutritional Biochemistry, vol. 25, no. 11, pp. 1226–1234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Maso, A. K. Calgarotto, G. C. Franchi et al., “Multitarget effects of quercetin in leukemia,” Cancer Prevention Research, vol. 7, pp. 1240–1250, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Hasima and B. Ozpolat, “Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer,” Cell Death and Disease, vol. 5, no. 11, article e1509, 2014. View at Publisher · View at Google Scholar